Zobrazeno 1 - 10
of 399
pro vyhledávání: '"Metastatic non-small cell lung cancer"'
Publikováno v:
Cancer Pathogenesis and Therapy, Vol 2, Iss 2, Pp 103-111 (2024)
Background: Chemotherapy remains the standard-of-care for many patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC), but acquired resistance presents challenges. The aim of this open-label, multicenter phase 2 clinical tria
Externí odkaz:
https://doaj.org/article/feec319524834ec39d25c999ea53f1d8
Publikováno v:
Thoracic Cancer, Vol 15, Iss 8, Pp 642-653 (2024)
Abstract Background The optimal timing of thoracic radiotherapy (TRT) in driver‐gene‐negative metastatic non‐small cell lung cancer (mNSCLC) patients was retrospectively investigated based on survival and safety profile. Methods The efficacy an
Externí odkaz:
https://doaj.org/article/92c5347463484f8ba6b483c5cc69968b
Publikováno v:
Cancer Medicine, Vol 13, Iss 5, Pp n/a-n/a (2024)
Abstract Background Tumor‐treating field (TTFields) was a novel antitumor therapy that provided significant survival for previously treated metastatic non‐small cell lung cancer (mNSCLC). The consistency of the cost of the new treatment regimen w
Externí odkaz:
https://doaj.org/article/d36a2b4b8b814dea94367e404b14dffa
Autor:
Laure Vacher, Maureen Bernadach, Ioana Molnar, Judith Passildas‐Jahanmohan, Pascale Dubray‐Longeras
Publikováno v:
Health Science Reports, Vol 7, Iss 1, Pp n/a-n/a (2024)
Abstract Background and Aims The treatment of metastatic non‐small‐cell lung cancer (NSCLC) has been revolutionized by the arrival of immune checkpoint inhibitors (ICI). For patients without immune related adverse events (irAEs), it is recommende
Externí odkaz:
https://doaj.org/article/98757861f86e4525868fd9e12b5ef347
Autor:
Shristi Upadhyay Banskota, Jonathan Q. Trinh, Elizabeth Lyden, Conor Houlihan, Samia Asif, Omar Abughanimeh, Benjamin A. Teply
Publikováno v:
Cancers, Vol 16, Iss 6, p 1221 (2024)
Purpose: The usual workup for patients newly diagnosed with advanced non-small cell lung cancer (NSCLC) occurs in the ambulatory setting. A subset of patients present with acute care needs and receive the diagnosis while hospitalized. Palliative ther
Externí odkaz:
https://doaj.org/article/8e4312072a144e4da8ee7602b5d52bb0
Publikováno v:
International Journal of General Medicine, Vol Volume 16, Pp 881-893 (2023)
Jing Huang,1,2,* Hongjiang Pu,3,* Jintao He,4 Xiaohu Tang5 1The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China; 2Department of Integrated Traditional Chinese and Western Medicine,
Externí odkaz:
https://doaj.org/article/93416c4169a6417d9382d591f719c97b
Autor:
Kittithat Taemkaew, Chaitong Churuangsuk, Khanin Khanungwanitkul, Warangkana Keeratichananont, Pramot Tanutit, Tippawan Liabsuetrakul
Publikováno v:
Journal of Health Science and Medical Research (JHSMR), Vol 42, Iss 1, Pp e2023980-e2023980 (2023)
Objective: Lung cancer is the leading cause of cancer-related deaths. Although, previous research have shown that patients with non-small-cell lung cancer (NSCLC), with a higher body mass index (BMI), have a lower risk of death, only a few studies ha
Externí odkaz:
https://doaj.org/article/2f88b23c9e3a45d08735baa5154811ee
Autor:
Kang Qin, Kaiwen Wang, Shenduo Li, Lingzhi Hong, Priyadharshini Padmakumar, Rinsurongkawong Waree, Shawna M. Hubert, Xiuning Le, Natalie Vokes, Kunal Rai, Ara Vaporciyan, Don L. Gibbons, John V. Heymach, J. Jack Lee, Scott E. Woodman, Caroline Chung, David A. Jaffray, Mehmet Altan, Yanyan Lou, Jianjun Zhang
Publikováno v:
Cancers, Vol 16, Iss 5, p 935 (2024)
Docetaxel +/− ramucirumab remains the standard-of-care therapy for patients with metastatic non-small-cell lung cancer (NSCLC) after progression on platinum doublets and immune checkpoint inhibitors (ICIs). The aim of our study was to investigate w
Externí odkaz:
https://doaj.org/article/68c251418d4743f6b9241d34d39e8b1a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.